[1] Maynard A D. Nanotechnology: A research strategy for addressing risk [R]. Washington, DC, USA:Woodrow Wilson International Center for Scholars,2006.
[2] Nel A, Xia T, M¨adler L, et al. Toxic potential of materials at the nanolevel [J]. Science, 2006, 311: 622-627.
[3] Gao X H, Cui Y Y, Levenson R M, et al. In vivo cancer targeting and imaging with semiconductor quantum dots [J]. Nature Biotechnology, 2004, 22(8):969-976.
[4] Cormode D P, Jarzyna P A, MulderWJ M, et al.Modified natural nanoparticles as contrast agents for medical imaging [J]. Advanced Drug Delivery Review,2010, 62(3): 329-338.
[5] Mccomas K A, Besley J C. Fairness and nanotechnology concern [J]. Risk Analysis, 2011, 31(11): 1749-1761.
[6] Dransfield G P. Inorganic sunscreens [J]. Radiation Protection Dosimetry, 2000, 91(1-3): 271-273.
[7] Antoniou C, Kosmadaki M G, Stratigos A J, et al. Sunscreens: What’s important to know [J]. Journal of the European Academy of Dermatology and Venereology,2008, 22: 1110-1118.
[8] British Standards Institution (BSI). PAS136 terminology for nanomaterials [EB/OL]. (2011-03-12).http: // www.bsigroup.com / en / sectorsandservices /Forms/PAS-136/Download-PAS-136.
[9] Tan M H, Commens C A, Burnett L, et al. A pilot study on the percutaneous absorption of microfine titanium dioxide from sunscreens [J]. Australasian Journal of Dermatology, 1996, 37(4): 185-187.
[10] Lademann J, Weigmann H J, Rickmeyer C, et al. Penetration of titanium dioxide microparticles in a sunscreen formulation into the horny layer and the follicular orifice [J]. Skin Pharmacology and Applied Skin Physiology, 1999, 12: 247-256.
[11] Schulz J, Hohenberg H, Pfl¨ucker F, et al. Distribution of sunscreens on skin [J]. Advanced Drug Delivery Review, 2002, 54(Sup 1): 157-163.
[12] Gottbrath S, M¨uller-Goymann C. Penetration,and visualization of titanium dioxide microparticles in human stratum corneum: Effect of different formulations on the penetration of titanium dioxide [J]. SOFW Journal, 2003, 3(1): 11-17.
[13] Butz T, Reiner T, Philippe M. Quality of skin as a barrier to ultra-fine particles [EB/OL]. (2006-07-19).http://www.unileipzig.de/nanoderm/index.html.
[14] Menzel F, Reinert T, Vogt J, et al. Investigations of percutaneous uptake of ultrafine TiO2 particles at the high energy ion nanoprobe LIPSION [J]. Nuclear Instruments and Methods in Physics Research Section B, 2004, 219-220: 82-86.
[15] Kert′esz Z, Szikszai Z, Gontier E, et al. Nuclear microprobe study of TiO2-penetration in the epidermis of human skin xenografts [J]. Nuclear Instruments and Methods in Physics Research Section B, 2005, 231:280-285.
[16] Mavon A, Miquel C, Lejeune O, et al. In vitro percutaneous absorption and in vivo stratum corneum distribution of an organic and a mineral sunscreen [J].Skin Pharmacology and Applied Skin Physiology, 2007,20: 10-20.
[17] Gamer A O, Leibold E, Van Ravenzwaay B. The in vitro absorption of microfine zinc oxide and titanium dioxide through porcine skin [J]. Toxicology in Vitro,2006, 20: 301-307.
[18] Zvyagin A V, Zhao X, Gierden A, et al. Imaging of zinc oxide nanoparticle penetration in human skin in vitro and in vivo [J]. Journal of Biomedical Optics,2008, 13(6): 064031.
[19] Wu J, Liu W, Xue C B, et al. Toxicity and penetration of TiO2 nanoparticles in hairless mice and porcine skin after subchronic dermal exposure [J]. Toxicology Letters, 2009, 191: 1-8.
[20] Sadrieh N, Wokovich A M, Gopee N V, et al. Lack of significant dermal penetration of titanium dioxide from sunscreen formulations containing nano-and submicron-size TiO2 particles [J]. Toxicological Sciences,2010, 155(1): 156-166.
[21] Michalet X, Pinaud F F, Bentolila L A, et al.Quantum dots for live cells, in vivo imaging, and diagnostics[J]. Science, 2005, 307: 538-544.
[22] Hoshino A, Fujioka K, Oku T, et al. Physicochemical properties and cellular toxicity of nanocrystal quantum dots depend on their surface modification [J].Nano Letters, 2004, 4(11): 2163-2169.
[23] Kirchner C, Liedl T, Kudera S, et al. Cytotoxicity of colloidal CdSe and CdSe/ZnS nanoparticles [J].Nano Letters, 2005, 5(2): 331-338.
[24] Ryman-Rasmussen J P, Riviere J E, Monteiro-Riviere N A. Penetration of intact skin by quantum dots with diverse physicochemical properties [J]. Toxicological Sciences, 2006, 91(1): 159-165.
[25] Zhang L W, Monteiro-Riviere N A. Assessment of quantum dot penetration into intact, tape-stripped,abraded and flexed rat skin [J]. Skin Pharmacology and Applied Skin Physiology, 2008, 21: 166-180.
[26] Jeong S H, Kim J H, Yi S M, et al. Assessment of penetration of quantum dots through in vitro and in vivo human skin using the human skin equivalent model and the tape stripping method [J]. Biochemical and Biophysical Research Communications, 2010, 394:612-615.
[27] Lopez R F V, Seto J E, Blankschtein D, et al. Enhancing the transdermal delivery of rigid nanoparticles using the simultaneous application of ultrasound and sodium lauryl sulfate [J]. Biomaterials, 2011, 32(3):933-941.
[28] Qin G, Geng S Y, Wang L P, et al. Charge influence of liposome on transdermal delivery efficacy [J]. Soft Matter, 2013, 9: 5649-5656.
[29] Ryman-Rasmussen J P, Riviere J E, Monteiro-Riviere N A. Surface coatings determine cytotoxicity and irritation potential of quantum dot nanoparticles in epidermal keratinocytes [J]. Journal of Investigative Dermatology, 2007, 127: 143-153.
[30] Prow T W, Monteiro-Riviere N Y, Inman A O,et al. Quantum dot penetration into viable human skin[J]. Nanotoxicology, 2012, 6(2): 173-185.
[31] Mortensen L J, Jatana S, Gelein R, et al. Quantification of quantum dot murine skin penetration with UVR barrier impairment [J]. Nanotoxicology, 2013,7(8): 1386-1398.
[32] Tang L, Zhang C L, Song G M, et al. In vivo skin penetration and metabolic path of quantum dots [J].Science China, 2013, 56(2): 181-188.
[33] Chu M Q, Wu Q, Wang J X, et al. In vitro and in vivo transdermal delivery capacity of quantum dots through mouse skin [J]. Nanotechnology, 2007, 18:455103.
[34] Wang L P, Qin G, Geng S Y, et al. Preparation of zein conjugated quantum dots and their in vivo transdermal delivery capacity through nude mouse skin [J]. Journal of Biomedical Nanotechnology, 2013, 9(3):367-376.
[35] Jain P, Pradeep T. Potential of silver nanoparticlecoated polyurethane foam as an antibacterial water filter [J]. Biotechnology Silver Nanoparticle and Bioengineering,2005, 90(1): 59-63.
[36] Ray R C, Yu H, Fu P P. Toxicity and environmental risks of nanomaterials: Challenges and future needs [J]. Journal of Environmental Science and Health, Part C: Environmental Carcinogenesis and Ecotoxicology Reviews, 2009, 27(1): 1-35.
[37] Trop M, Novak M, Rodl S, et al. Silver-coated dressing acticoat caused raised liver enzymes and argyria-like symptoms in burn patient [J]. The Journal of Trauma, 2006, 60(3): 648-652.
[38] Lu W T, Senapati D, Wang S G, et al. Effect of surface coating on the toxicity of silver nanomaterials on human skin keratinocytes [J]. Chemical Physics Letters, 2010, 487: 92-96.
[39] Koohi M K, Hejazy M, Asadi F, et al. Assessment of dermal exposure and histopathologic changes of different sized nano-silver in healthy adult rabbits [J]. Journal of Physics: Conference Series, 2011, 304: 012028.
[40] Samberg M E, Oldenburg S J, Monteiro-Riviere N A. Evaluation of silver nanoparticle toxicity in skin in vivo and keratinocytes in vitro [J]. Environmental Health Perspectives, 2010, 118(3): 407-413.
[41] Korani M, Rezayat S M, Bidgoli S A. Sub-chronic dermal toxicity of silver nanoparticles in Guinea pig:Special emphasis to heart, bone and kidney toxicities [J]. Iranian Journal of Pharmaceutical Research, 2013,12 (3): 511-519.
[42] Connor E E, Mwamuka J, Gole A, et al. Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity [J]. Small, 2005, 1(3): 325-327.
[43] Sonavane G, Tomoda K, Sano A, et al. In vitro permeation of gold nanoparticles through rat skin and rat intestion: Effect of particle size [J]. Colloids Surface B: Biointerfaces, 2008, 65: 1-10.
